meaxin (▼) 100 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - imatinib - filmom obložena tableta - 100 mg/1 tableta - 1 filmom obložena tableta sadrži: 100 mg imatiniba (u obliku imatinibmesilata)
cerdelga (▼) 84,4 mg/1 kapsula kapsula, tvrda
sanofi d.o.o. - eliglustat - kapsula, tvrda - 84,4 mg/1 kapsula - 1 kapsula, tvrda sadrži: 84,4 mg eliglustata (u obliku eliglustat tartarata)
enbrel 10 mg/1 bočica prašak i otapalo za otopinu za injekciju
pfizer bh d.o.o. - etanercept - prašak i otapalo za otopinu za injekciju - 10 mg/1 bočica - 1 bočica sa praškom za otopinu za injekciju sadrži: 10 mg etanercepta; 1 šprica sa otapalom sadrži: 1 ml vode za injekcije
enbrel 25 mg/1 bočica prašak i otapalo za otopinu za injekciju
pfizer bh d.o.o. - etanercept - prašak i otapalo za otopinu za injekciju - 25 mg/1 bočica - 1 bočica sa praškom za otopinu za injekciju sadrži: 25 mg etanercepta; 1 šprica sa otapalom sadrži: 1 ml vode za injekcije
libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - ostali lijekovi protiv živčanog sustava - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.
eslikarbazepinacetat accord 200 mg tablete
accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - eslicarbazepinum - tableta - 200 mg - urbroj: jedna tableta sadrži 200 mg eslikarbazepinacetata
eslikarbazepinacetat accord 800 mg tablete
accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - eslicarbazepinum - tableta - 800 mg - urbroj: jedna tableta sadrži 800 mg eslikarbazepinacetata
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - imuni serumi i homologna, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicin hidroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
oxaliplatinum accord 5 mg/1 ml koncentrat za rastvor za infuziju
evropa lijek pharma d.o.o. - oksaliplatin - koncentrat za rastvor za infuziju - 5 mg/1 ml - 1 bočica sadrži.5 mg oksaliplatina